Orchestra BioMed Holdings (OBIO) Enterprise Value (2022 - 2025)
Historic Enterprise Value for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$127.8 million.
- Orchestra BioMed Holdings' Enterprise Value fell 3326.07% to -$127.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$127.8 million, marking a year-over-year decrease of 3326.07%. This contributed to the annual value of -$101.4 million for FY2024, which is 2842.31% up from last year.
- Orchestra BioMed Holdings' Enterprise Value amounted to -$127.8 million in Q3 2025, which was down 3326.07% from -$39.5 million recorded in Q2 2025.
- In the past 5 years, Orchestra BioMed Holdings' Enterprise Value registered a high of -$735217.0 during Q3 2022, and its lowest value of -$235.0 million during Q1 2023.
- Over the past 4 years, Orchestra BioMed Holdings' median Enterprise Value value was -$101.4 million (recorded in 2024), while the average stood at -$105.1 million.
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 2612355.03% in 2023, then soared by 5859.81% in 2025.
- Quarter analysis of 4 years shows Orchestra BioMed Holdings' Enterprise Value stood at -$146.5 million in 2022, then grew by 3.33% to -$141.6 million in 2023, then rose by 28.42% to -$101.4 million in 2024, then dropped by 26.06% to -$127.8 million in 2025.
- Its Enterprise Value stands at -$127.8 million for Q3 2025, versus -$39.5 million for Q2 2025 and -$71.7 million for Q1 2025.